Post-asphyxia perinatal brain injury is a leading cause of neonatal encephalopathy, a serious healthcare problem. Cerebral vascular dysfunction may lead to adverse neurological sequelae. This proposal is designed to provide new understanding of perinatal asphyxia-induced cerebral vascular dysfunction, endogenous protection, and outline potential approaches for intervention. The proposal is built on our previous accomplishments of discovering hydrogen sulfide (H2S) as a critical component of regulation of newborn cerebral blood flow regulation. The proposed experiments are novel, critically important and have direct applicability to a devastating pathological condition. Preliminary data suggest H2S formed by endothelial cystathionine-?-lyase (CSE) provides protection from asphyxia-induced cerebral vascular damage. The research proposed pursues the unifying hypothesis that, in newborn brain, asphyxia disrupts vascular H2S signaling and cerebral arteriolar smooth muscle KATP and/or BKCa channel activity causing cerebrovascular dysfunction, while elevation of H2S limits the dysfunction. To test this hypothesis, four specific hypotheses will be tested using a novel asphyxia model in newborn pigs: 1. Asphyxia injures cerebrovascular endothelial cells causing loss of H2S-mediated pial arteriole dilation. 2. Asphyxia reduces H2S-induced Ca spark and BKCa 2+ channel activation, and vasodilation. 3. Asphyxia inhibits H2S-induced KATP channel activation and vasodilation. 4. H2S reduces asphyxia-induced ROS and post-asphyxia vascular dysfunction. A multi system approach combining in vivo and in vitro techniques is unique and advantageous to uncover mechanisms responsible for cerebral vascular dysfunction. Cranial windows allow observation of the microcirculation, collection of cortical CSF and topical application of agonists, precursors and inhibitors. H2S production in vivo and in vitro is identified and quantified by gas chromatography-mass spectrometry and a selective electrode. Cerebral arterioles, and endothelial and smooth muscle cells from control and post-asphyxia brains allow study of H2S production, arteriolar reactivity, and vascular smooth muscle function. Patch clamp techniques will be used to examine BKCa channel activity. Global cytosolic Ca and Ca sparks in intact arterioles and VSM will be studied 2+ 2+ using fluorescent indicator technology with a dual excitation, single emission system and laser scanning confocal microscopy, respectively. Importantly, experimental interventions that may attenuate cerebrovascular malfunction caused by asphyxia are examined. The research proposed is highly significant in addressing a major cause of perinatal morbidity and mortality in a manner that could result in new approaches for prevention and treatment of post-asphyxia perinatal brain injury, a serious healthcare problem both in cost and lifelong disabilities.

Public Health Relevance

Asphyxia may cause perinatal brain injury that leads to lifelong disabilities in survivors. The specific focus of this project is on the endogenous mechanisms that prevent loss of cerebral vascular function following asphyxia that can lead to neonatal brain injury. Understanding mechanisms of asphyxia-related loss of cerebral blood flow regulation is essential in improving the long-term neurological outcome of human newborns.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL042851-25
Application #
9028344
Study Section
Pregnancy and Neonatology Study Section (PN)
Program Officer
Reid, Diane M
Project Start
1991-08-16
Project End
2019-12-31
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
25
Fiscal Year
2016
Total Cost
$391,127
Indirect Cost
$133,806
Name
University of Tennessee Health Science Center
Department
Physiology
Type
Schools of Medicine
DUNS #
941884009
City
Memphis
State
TN
Country
United States
Zip Code
38103
Pourcyrous, Massroor; Chilakala, Sandeep; Elabiad, Mohamad T et al. (2018) Does prolonged severe hypercapnia interfere with normal cerebrovascular function in piglets? Pediatr Res 84:290-295
Liu, Jianxiong; Pourcyrous, Massroor; Fedinec, Alex L et al. (2017) Preventing harmful effects of epileptic seizures on cerebrovascular functions in newborn pigs: does sex matter? Pediatr Res 82:881-887
Harsono, Mimily; Pourcyrous, Massroor; Jolly, Elliott J et al. (2016) Selective head cooling during neonatal seizures prevents postictal cerebral vascular dysfunction without reducing epileptiform activity. Am J Physiol Heart Circ Physiol 311:H1202-H1213
Chang, Jennifer; Fedinec, Alexander L; Kuntamallappanavar, Guruprasad et al. (2016) Endothelial Nitric Oxide Mediates Caffeine Antagonism of Alcohol-Induced Cerebral Artery Constriction. J Pharmacol Exp Ther 356:106-15
Liu, Jianxiong; Fedinec, Alexander L; Leffler, Charles W et al. (2015) Enteral supplements of a carbon monoxide donor CORM-A1 protect against cerebrovascular dysfunction caused by neonatal seizures. J Cereb Blood Flow Metab 35:193-9
Pourcyrous, Massroor; Basuroy, Shyamali; Tcheranova, Dilyara et al. (2015) Brain-derived circulating endothelial cells in peripheral blood of newborn infants with seizures: a potential biomarker for cerebrovascular injury. Physiol Rep 3:
Nnorom, Chukwuma C; Davis, Corinne; Fedinec, Alexander L et al. (2014) Contributions of KATP and KCa channels to cerebral arteriolar dilation to hypercapnia in neonatal brain. Physiol Rep 2:
Bukiya, Anna; Dopico, Alejandro M; Leffler, Charles W et al. (2014) Dietary cholesterol protects against alcohol-induced cerebral artery constriction. Alcohol Clin Exp Res 38:1216-26
Basuroy, Shyamali; Leffler, Charles W; Parfenova, Helena (2013) CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis. Am J Physiol Cell Physiol 304:C1105-15
Bukiya, Anna N; McMillan, Jacob E; Fedinec, Alexander L et al. (2013) Cerebrovascular dilation via selective targeting of the cholane steroid-recognition site in the BK channel ?1-subunit by a novel nonsteroidal agent. Mol Pharmacol 83:1030-44

Showing the most recent 10 out of 58 publications